Longwood Healthcare Leaders meetings bring together leading biotech and pharma CEOs, heads of R&D, top academics, and healthcare investors for off-the-record discussions to drive transparency and collaboration in order to accelerate the translation of discoveries into medicines to help patients. Substantial donations enabled by these meetings benefit several charities. 

Upcoming
Meeting

Our Fall webconference will bring together leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors for an off-the-record forum focused on accelerating the translation of discoveries into medicines to help patients.

September 21 - 22, 2022

Meetings are invitation-only. To request an invitation or recommend a colleague, email julie@longwoodfund.com. Meetings take place without the presence of media and participants are asked not to post anything shared in discussion to social media.

Featured Speakers

These and other top industry leaders joined us at the recent
Longwood Healthcare Leaders Webconferences

Regulatory, Government, & Advocacy

Janet Woodcock

Acting Commissioner 

FDA

Victor Dzau

President

National Academy of Medicine

Peter Marks

Director, CBER

FDA

Rich Moscicki

CMO & EVP, Science & Regulatory Advocacy  PhRMA

Henry Walke 

Director of the Center for Preparedness and Response CDC

Jay Bradner 

President

NIBR

Biopharma CEOs

Alisha Alaimo

President, US
Biogen

Glenn Gormley

PExecutive Chair
Daiichi Sankyo

Paul Hastings

CEO

Nkarta Therapeutics

Bob Langer 

Co-Founder 

Momenta 

David Loew 

CEO

Ipsen 

John Maraganore 

former CEO

Alnylam

Ivana Magovcevic-Liebisch

CEO

Vigil Neuroscience

Ted Love

CEO

Global Blood Therapeutics

Kabir Nath 

CEO

Otsuka US

Stefan Oelrich 

CEO

Bayer Pharma 

Paul Perreault

CEO

CSL

Clay Siegall

President, CEO, Chairman
Seattle Genetics 

Joanne Smith-Farrell

CEO

Be Biopharma 

Dave Ricks 

Chair & CEO

Eli Lily 

David Pyott

former CEO 

Allergan​

R&D Leaders